BioPharma
Er-Kim Announces Exclusive Agreement with CNX Therapeutics to Distribute Oncology Products Across CEE and Turkey
Partnership will broaden portfolio distribution of oncology products to cancer patients in the specified regions
Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced a distribution agreement with CNX Therapeutics to supply selected oncology products across Central...
Press Releases
Record international attendance at CPHI & PMEC China 2025 as China in-licensing deals and international partnering increase
China’s biotech sector is now a key driver of innovation across global pipelines, as CPHI Shenzhen prepares for largest ever influx of foreign dealmakers
Sino-international trade is accelerating as CPHI & PMEC China (June 24–26, 2025) reported a record-breaking international...
Packaging & Labelling
Autopack to host biggest packaging machinery stand at PPMA Total 2025
Leading independent integrator of packaging lines Autopack will showcase a range of cutting-edge automated equipment at PPMA Total 2025, which takes place at Birmingham’s NEC from 23-25 September. The Hereford-based business will take its largest individual stand to date in what...
Press Releases
Friends of Cancer Research and MMS Collaborate to Develop Decision Frameworks for Interim Overall Survival Data in Oncology Trials
MMS, a global, data-focused clinical research organization (CRO), announced today that it has been chosen by Friends of Cancer Research (Friends), a leading nonprofit dedicated to accelerating innovation in cancer research, to support the development of practical decision frameworks...
Clinical Trials
PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery
PADCEV plus KEYTRUDA is the first and only regimen to improve survival when used before and after standard of care (surgical cystectomy) in cisplatin-ineligible patients with muscle-invasive bladder cancer
Results will be discussed with global health authorities for...
Press Releases
Receptor.AI Announces Collaboration with Sareum to Accelerate Discovery of BBB-Permeable TYK2/JAK1 Inhibitors for Neuroinflammatory Diseases
London, UK — August 14, 2025 — Receptor.AI, an AI- and technology-driven drug discovery company, today announced a strategic collaboration with Sareum Holdings plc (AIM: SAR), a clinical-stage biotechnology company developing next-generation kinase inhibitors.
The collaboration will focus on the...
Press Releases
Global healthcare AI experts and former UK Health Minister back AI that detects healthcare-associated infections up to 72 hours earlier
Sanome’s MEMORI becomes the first UK‑built, Certified Class IIb Software-as-a-Medical Device for real-time infection prediction, ahead of NHS rollout and FDA approval.
AI tool that spots hospital infections up to 72 hours early, newly backed by former health minister...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















